Status:
COMPLETED
Serum Exosomal Long Noncoding RNAs as Potential Biomarkers for Lung Cancer Diagnosis
Lead Sponsor:
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Conditions:
Lung Cancer (Diagnosis)
Eligibility:
All Genders
18-75 years
Brief Summary
The study is to investigate the sensitivity and specificity of serum exosome noncoding RNA as a biomarker for the diagnosis of lung cancer
Detailed Description
Conventional tumor markers for non-invasive diagnosis of Lung cancer (LC) exhibit insufficient sensitivity and specificity to facilitate detection of early lung cancer (ELC). The investigators aimed t...
Eligibility Criteria
Inclusion
- Subjects are willing to sign the informed consent form;
- Normal subjects have no evidence of any disease;
- Lung cancer patients are 18 to 75 years old, diagnosed as lung cancer by histopathology or cytopathology
Exclusion
- People are unwilling to sign the informed consent form;
- Patients with heart disease, rheumatic disease, allergic disease, COPD, pulmonary fibrosis, diabetes, thyroid disease, liver, kidney, brain disease and hematopoietic system disease;
- Pregnant or lactating women;
- Patients did not cooperate or participate in other clinical trials
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03830619
Start Date
January 1 2017
End Date
July 31 2021
Last Update
November 22 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430022